Browse by author
Lookup NU author(s): Christopher McKee,
Dr David Hill,
Dr Chris RedfernORCiD,
Dr Jane Armstrong,
Professor Penny Lovat
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The Bcl-2 family member Mcl-1 is essential for melanoma survival; however, the influence of oncogenic BRAF signalling remains elusive. In this study, Mcl-1 splice variant expression was determined in a panel of melanoma cell lines in relation to BRAF mutational status. Mcl-1L mRNA expression was increased in melanoma cells compared with primary melanocytes with significantly increased mRNA and protein expression observed in BRAF(V600E) mutant melanoma cells. Although no change in Mcl-1S mRNA was observed, Mcl-1S protein expression also increased in BRAF mutant melanoma cells. Additionally, while over-expression of mutant BRAF(V600E) increased both Mcl-1L and Mcl-1S expression, inhibition of hyperactive BRAF signalling resulted in decreased Mcl-1L expression. These studies suggest that the regulation of Mcl-1 expression by BRAF signalling is increased by oncogenic activation of BRAF, revealing a mechanism of apoptotic resistance which may be overcome by the use of more specifically targeted Mcl-1 inhibitors.
Author(s): McKee CS, Hill DS, Redfern CPF, Armstrong JL, Lovat PE
Publication type: Article
Publication status: Published
Journal: Experimental Dermatology
Print publication date: 29/10/2013
ISSN (print): 0906-6705
ISSN (electronic): 1600-0625
Altmetrics provided by Altmetric